CN1112435A - Potent pearl eye drops - Google Patents
Potent pearl eye drops Download PDFInfo
- Publication number
- CN1112435A CN1112435A CN94111435A CN94111435A CN1112435A CN 1112435 A CN1112435 A CN 1112435A CN 94111435 A CN94111435 A CN 94111435A CN 94111435 A CN94111435 A CN 94111435A CN 1112435 A CN1112435 A CN 1112435A
- Authority
- CN
- China
- Prior art keywords
- medium liquid
- water medium
- eye drops
- pearl
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The pearl eye drops consists of pearl hydrolysate 88-97%, red leech hydrolysate 0.5-3.3%, plum blossom 0.2-1.8%, mint 0.5-3.3%, boric acid 0.5-1.5%, sodium chloride 0.3-0.9%, nipagin 0.01-0.1%, polyvinylpyrrolidone (K30) 0.1-1%, and is prepared by the processes of extracting, mixing, adjusting of pH value and osmosis pressure and filtrating, it is effective on prevention of senile cataract and improvement in vision.
Description
What the present invention proposed is a kind of pearl eye drops.Belong to field of pharmaceutical technology.
Prior art is as the ZHENZHU MINGMUYE of production and sales in the market.Its composition also has Margarita water medium liquid etc.But shy sense is arranged after it uses, and it is slower to take effect, not obvious.And it only acts on eye surface, and its physical and chemical index changes with the change of temperature and surrounding.
The objective of the invention is to effectively overcome the defective of above-mentioned existence, therapeutic effect is remarkable.Refrigerant, comfortable, moisture feeling are arranged after the use immediately.
Technical solution of the present invention: its proportioning components: Margarita water medium liquid 88-97%, Hirudo water medium liquid 0.5-3.3%, borneol 0.2-1.8%, Herba Menthae 0.5-3.3%, boric acid 0.5-1.5%, sodium chloride 0.3-0.9%, nipalgin 0.01-0.1%, polyethylene pyrrolinone (K30) 0.1-1.0%; (unit of weight).Its technological process is that (1) each composition is got ready in the proportioning ratio, (2) under 110 ℃ of temperature, carry out Hirudo water medium liquid, Margarita water medium liquid, Herba Menthae extracting solution, time is 24-48 hour, (3) all compositions are mixed vibration and stir 24 hours (room temperature), (4) add micro-antiseptic, (5) (being suitable for eye uses to regulate pH value, 4.5-7.5PH value), (6) regulate osmotic pressure and reach the human body fluid unanimity, meet the medicine inspection standard, (7) Filtration commonly used filters clear and bright, (8) quality inspection, (9) filling and package, (10) product inspection.
Embodiment: adopt following three embodiment of process choice of the present invention to be described.
Proportioning components (example 1) proportioning (example 2) proportioning (example 3)
Margarita water medium liquid 0.97 0.91 0.88
Hirudo water medium liquid 0.005 0.001 0.033
Borneol 0.002 0.025 0.018
Herba Menthae 0.005 0.015 0.033
Boric acid 0.005 0.009 0.015
Sodium chloride 0.003 0.006 0.009
Nipalgin 0.0001 0.00055 0.001
Polyethylene pyrrolinone (K30) 0.001 0.0055 0.01
(unit of weight)
Through clinic trial, the control of senile cataract is reached 92%, improve vision 〉=80%, use and reduce intraocular pressure in 15 minutes and reach 98%.Use the back eyes to produce refrigerant, comfortable, moisture feeling immediately in addition, eyes become clear, it is clear to look thing.Use the present invention pleasing to the eye → cornea → conjunctiva → aqueous humor → iris → crystalline lens and vitreous body → retina choroid.It is not only eye surface.The physical and chemical index of product does not become with temperature and surrounding.5 years effect duration.
Claims (2)
1, pearl eye drops is characterized in that its proportioning components: Margarita water medium liquid 88-97%, Hirudo water medium liquid 0.5-3.3%, borneol 0.2-1.8%, Herba Menthae 0.5-3.3%, boric acid 0.5-1.5%, sodium chloride 0.3-0.9%, nipalgin 0.01-0.1%, polyethylene pyrrolinone (K30) 0.1-1.0%; (unit of weight)
2, pearl eye drops, the technological process that it is characterized in that it is that (1) each composition is got ready in the proportioning ratio, (2) under 110 ℃ of temperature, carry out the Hirudo water medium liquid, the Margarita water medium liquid, the Herba Menthae extracting solution, time is 24-48 hour, (3) all compositions are mixed vibration and stir 24 hours (room temperature), (4) add micro-antiseptic, (5) (being suitable for eye uses to regulate pH value, 4.5-7.5PH value), (6) are regulated osmotic pressure and are reached the human body fluid unanimity, meet the medicine inspection standard, (7) Filtration commonly used filters clear and bright, (8) quality inspection, (9) filling and package, (10) product inspection.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94111435A CN1062141C (en) | 1994-09-10 | 1994-09-10 | Potent pearl eye drops |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94111435A CN1062141C (en) | 1994-09-10 | 1994-09-10 | Potent pearl eye drops |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1112435A true CN1112435A (en) | 1995-11-29 |
| CN1062141C CN1062141C (en) | 2001-02-21 |
Family
ID=5035303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN94111435A Expired - Fee Related CN1062141C (en) | 1994-09-10 | 1994-09-10 | Potent pearl eye drops |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1062141C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100423731C (en) * | 2004-01-01 | 2008-10-08 | 北海国发海洋生物产业股份有限公司 | Eye brightening eye washing liquid and its preparation method |
| CN101549067B (en) * | 2009-04-13 | 2011-11-02 | 俞寿良 | Chinese medicinal composition and uses thereof |
| US9744196B2 (en) | 2012-10-24 | 2017-08-29 | N2 Pharmaceuticals Ltd | Composition for parenteral administration, method for producing and method use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1033154A (en) * | 1987-11-20 | 1989-05-31 | 李际云 | A kind of collyrium |
| CN1076113A (en) * | 1992-03-11 | 1993-09-15 | 贺茂麟 | A kind of collyrium and preparation thereof |
| CN1088813A (en) * | 1993-01-01 | 1994-07-06 | 程俊芬 | " Kanghongyi " antiflammatory eyedrops |
-
1994
- 1994-09-10 CN CN94111435A patent/CN1062141C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100423731C (en) * | 2004-01-01 | 2008-10-08 | 北海国发海洋生物产业股份有限公司 | Eye brightening eye washing liquid and its preparation method |
| CN101549067B (en) * | 2009-04-13 | 2011-11-02 | 俞寿良 | Chinese medicinal composition and uses thereof |
| US9744196B2 (en) | 2012-10-24 | 2017-08-29 | N2 Pharmaceuticals Ltd | Composition for parenteral administration, method for producing and method use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1062141C (en) | 2001-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1062141C (en) | Potent pearl eye drops | |
| CN102357196A (en) | External traditional Chinese medicine composition for treating xerophthalmia and preparation method thereof | |
| CN112022938B (en) | Hydrogel eye patch for relieving asthenopia and preventing myopia and preparation method thereof | |
| CN1011118B (en) | Eyedrops for cataract and their preparation | |
| CN112494466A (en) | Preparation process of eye-protecting soft capsule | |
| US20210228516A1 (en) | Eye drops that cure cataracts presbyopia and | |
| CN110693746A (en) | Cosmetic for relieving eye fatigue and preparation method thereof | |
| CN1132584C (en) | Myopia treating eye drop | |
| JPH10218760A (en) | Eye drop with small amount of oil added for treating dry eye | |
| CN105983006A (en) | Composition for relieving visual fatigue and preparation method of composition | |
| CN101897896B (en) | Chinese medicinal composition for treating cataract and medicinal preparation and preparation method thereof | |
| CN111346034A (en) | Chinese herbal medicine eye massage cream | |
| DE19539532C2 (en) | Ophthalmic cromoglicate gel preparation | |
| CN1083360A (en) | Runshu eye drops and preparation method thereof | |
| CN105726697B (en) | Anti-asthenopia rose composition, eye drop and preparation method of eye drop | |
| CN1047523C (en) | Nearsight prevention eye drop solution | |
| CN1136442A (en) | Medicine for improving eyesight | |
| CN114146108A (en) | Formula of eye drop and preparation method thereof | |
| CN109188721A (en) | A kind of safety goggles | |
| CN1110101A (en) | Xuege oral liquor and its preparation method | |
| CN102318701A (en) | Eyesight improving health-care tea | |
| CN1287806C (en) | Preparation and technique for making compound leech eye drip | |
| CN117481276A (en) | Beverage with asthenopia relieving function and preparation method thereof | |
| JP2024024535A (en) | Chinese medicine eye drop and method for producing the same | |
| DE854257C (en) | Process for the production of adhesive glasses from thermoplastics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |